The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 22, 2015
Filed:
Oct. 01, 2012
Michael D. Altman, Needham, MA (US);
Corey E. Bienstock, Natick, MA (US);
John W. Butcher, Berlin, MA (US);
Kaleen Konrad Childers, Newton, MA (US);
Maria Emilia Di Francesco, Houston, TX (US);
Anthony Donofrio, Cambridge, MA (US);
John Michael Ellis, Needham, MA (US);
Christian Fischer, Natick, MA (US);
Andrew M. Haidle, Cambridge, MA (US);
James P. Jewell, Somerville, MA (US);
Sandra Lee Knowles, Princeton, NJ (US);
Alan B. Northrup, Reading, MA (US);
Ryan D. Otte, Natick, MA (US);
Scott L. Peterson, Salem, MA (US);
Graham Frank Smith, Sudbury, MA (US);
Michael D. Altman, Needham, MA (US);
Corey E. Bienstock, Natick, MA (US);
John W. Butcher, Berlin, MA (US);
Kaleen Konrad Childers, Newton, MA (US);
Maria Emilia Di Francesco, Houston, TX (US);
Anthony Donofrio, Cambridge, MA (US);
John Michael Ellis, Needham, MA (US);
Christian Fischer, Natick, MA (US);
Andrew M. Haidle, Cambridge, MA (US);
James P. Jewell, Somerville, MA (US);
Sandra Lee Knowles, Princeton, NJ (US);
Alan B. Northrup, Reading, MA (US);
Ryan D. Otte, Natick, MA (US);
Scott L. Peterson, Salem, MA (US);
Graham Frank Smith, Sudbury, MA (US);
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Abstract
The invention provides certain 2-pyridyl carboxamide-containing compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein A and B are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk) kinase.